Company Filing History:
42 out of 822 
5 out of 150 
3 out of 4,177 
Years Active: 2012-2023
Title: **Chung-Ming Hsieh: Innovator in Antibody Development**
Introduction
Chung-Ming Hsieh, based in Newton, MA, is a prolific inventor recognized for his significant contributions to the field of biotechnology. With 46 patents to his name, Hsieh has focused much of his work on the development of high-affinity antibodies and their applications in medical therapies, particularly in the treatment of disorders involving the prolactin receptor.
Latest Patents
Hsieh holds several groundbreaking patents, including:
1. **High Affinity Antibodies Targeting Tau Phosphorylated at Serine 413**: This patent describes high-affinity antibodies that specifically bind to human tau phosphorylated at serine 413. The invention encompasses relevant compositions, kits, methods, and applications involving these antibodies, aiming to provide innovative tools for research and potential therapeutic interventions.
2. **Prolactin Receptor Binding Proteins and Uses Thereof**: This invention covers PRLR binding proteins, specifically focusing on chimeric, CDR-grafted, and humanized antibodies with high affinity for the human prolactin receptor (hPRLR). These antibodies are designed to neutralize the activity of hPRLR in vitro and in vivo, and they can be utilized for detection and therapeutic purposes in disorders where hPRLR activity is detrimental. Additionally, this patent includes anti-PRLR antibody drug conjugates (ADCs), showcasing a multifaceted approach to treatment.
Career Highlights
Chung-Ming Hsieh has made significant advancements in antibody technology during his tenure at renowned companies such as AbbVie and its affiliate, AbbVie Deutschland GmbH & Co. KG. His contributions to the field have influenced both research and clinical practices related to antibody therapies and their mechanisms.
Collaborations
Throughout his career, Hsieh has collaborated with talented professionals, including Yuliya Kutskova and Lorenzo Benatuil. These collaborations have fostered innovation and contributed to the successful development of therapeutic antibodies and advanced biotechnology solutions.
Conclusion
Chung-Ming Hsieh's extensive patent portfolio and collaborative spirit underscore his role as a leading innovator in the biotechnology industry. As he continues to advance research and development in antibody technology, his work promises to impact treatments for various medical conditions, ultimately benefiting patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.